Mayur Abhaya has been heading LifeCell since 2008 and has been instrumental in improving family’s access to stem cells in India, through umbilical cord banking service, BabyCord, being established as global #2 in terms of new units being preserved each year. Under his leadership LifeCell has raised growth capital from Helion Ventures and spread LIfeCell’s operations across India. As part of this growth, Mayur Abhaya has also enabled creation of over 50 intrapreneurs. With a global-first initiative of BabyCord Share, a collaborative stem cell sharing program, Mayur Abhaya has led the company into the sharing economy, thereby creating substantial customer value. It is expected that parents in India will have higher future access to stem cells than even those enjoyed by patients in advanced countries such as the US. Mayur Abhaya has also extended LifeCell’s services by foraying into essential preventive diagnostics, BabyShield, targeted towards reducing the infant mortality ratio. With addressing gaps in marketplace and innovative business models it has established market leadership in newborn screening, and also acquired a prenatal screening service provider. Currently Mayur Abhaya is driving digital adoption across the organization not just to improve productivity but also lead to creation of newer service offerings which improve customer experience and lead to happier and healthier families. Mayur Abhaya, graduated in Masters in Biotechnology from Anna University, India and post-graduated from Northwestern University, USA. Prior to joining LifeCell, Mayur Abhaya served for many years at Shasun Pharmaceuticals, a leading provider of contract manufacturing services to global providers, where he led their New Product Development, Intellectual Property and Licensing initiatives.